http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0739209-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4f68df9c44e531e667e3e489ceddca4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-40
filingDate 1994-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43f577f506eb3e0f2f106969cdea4d19
publicationDate 1996-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0739209-A1
titleOfInvention Method for treatment of papulo-pustules and comedones of the skin
abstract Papulo-pustules in the skin of patients suffering from various forms of acne, folliculitis and rosacea may be rapidly resolved by a spot therapy which involves topically applying to the exterior surface of the papulo-pustule (pimple) an aqueous solution containing hydrogen peroxide and preferably also at least one fruit acid and/or salicylic acid. A preferred fruit acid is glycolic acid. Both open and closed comedones are also effectively treated by spot therapy with the aqueous solution containing hydrogen peroxide, fruit acid and salicylic acid. The solution preferably contains 3 to 6 weight percent hydrogen peroxide, 2 to 4 weight percent glycolic acid and 2 to 4 weight percent salicylic acid, and is preferably applied 2 to 3 times daily. Treatments continue for 1 to 3 days when directed to papulo-pustules and 7 to 20 days when directed to comedones. The therapy also substantially reduces or avoids hyperpigmentation and scarring after resorption of the papulo-pustules. Application of the hydrogen peroxide solution to the earliest spot (lesion) prevents development of larger papulo-pustules and reduces the possibility of scarring and hyperpigmentation.
priorityDate 1993-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0191214-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2068225-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4363815-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4485091-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4438102-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID379849
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID379849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1747
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1747

Total number of triples: 24.